Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» insulin
insulin
FDA Updates its Thinking on Immunogenicity Studies for Insulin Biosimilars, Interchangeables
RAPS.org
Tue, 11/26/19 - 09:43 am
FDA
diabetes
insulin
biosimilars
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Endpoints
Mon, 11/4/19 - 10:09 am
Sanofi
clinical trials
type 1 diabetes
insulin
Toujeo
‘Smart’ Inhaler Can Make Insulin Delivery Quick and Painless
Xtalks
Fri, 10/4/19 - 09:57 am
Aerami Therapeutics
insulin
smart inhalers
diabetes
Can Synthetic Biology Make Insulin Faster, Better and Cheaper?
Forbes
Sat, 09/21/19 - 12:39 pm
diabetes
insulin
drug pricing
Genentech
gene editing
The top drugs facing cuts under Pelosi's pricing plan
Biopharma Dive
Fri, 09/20/19 - 10:46 pm
drug pricing
Nancy Pelosi
regulatory
Revlimid
Keytruda
Opdivo
Januvia
insulin
Medicare
Employers Slowly Warm to Point-of-Sale Rebates—But Must Move Faster for Insulin
Drug Channels
Thu, 09/19/19 - 10:59 am
payer
rebates
point-of-sale rebates
drug pricing
insulin
Novo and Sanofi make case for hypo-reducing insulins at EASD
Pharmaforum
Thu, 09/19/19 - 09:59 am
Novo Nordisk
Sanofi
EASD
diabetes
hypoglycemia
insulin
Lantus
Tresiba
Factbox: Britain's insulin providers prepare for Brexit fallout
Yahoo/Reuters
Tue, 09/17/19 - 10:05 am
Novo Nordisk
Eli Lilly
Sanofi
UK
Brexit
insulin
diabetes
Novo Nordisk to cut insulin prices for some U.S. diabetics
Yahoo/Reuters
Fri, 09/6/19 - 10:08 am
Novo Nordisk
drug pricing
Novolog
insulin
diabetes
Analysis Shows Eli Lilly’s Half-Price Humalog Generic Is Not Readily Available Across the U.S.
BioSpace
Thu, 08/29/19 - 08:16 pm
diabetes
insulin
Humalog
generics
Eli Lilly
Lispro
Novo faces shareholder suit over insulin sales disclosures
Biopharma Dive
Fri, 08/16/19 - 12:54 pm
Novo Nordisk
insulin
investors
Most insurers don't cover Eli Lilly's half-priced insulin
Beckers Hospital Review
Mon, 08/12/19 - 05:30 pm
insulin
diabetes
drug pricing
Eli Lilly
PBMs
insurers
Eli Lilly confirms probe by New York’s Attorney General over insulin prices
CNBC
Mon, 08/5/19 - 10:34 pm
Eli Lilly
drug pricing
insulin
diabetes
New York
New York investigating 3 insulin makers' pricing strategies
Beckers Hospital Review
Tue, 07/30/19 - 11:09 pm
New York
insulin
diabetes
Sanofi
Eli Lilly
Novo Nordisk
Sanofi ends partnership with Lexicon to develop add-on pill for diabetes
Yahoo/Reuters
Sat, 07/27/19 - 01:58 pm
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
type 2 diabetes
diabetes
insulin
Why Isn’t Insulin a Complex Generic? PA Representative Asks FDA
RAPS.org
Tue, 07/16/19 - 12:00 pm
insulin
generics
FDA
With FDA spanking, Biocon and Mylan face new hurdle for Lantus challenger
Fierce Pharma
Mon, 07/8/19 - 10:18 pm
FDA
Biocon
Mylan
Sanofi
Lantus
insulin
drug manufacturing
Colorado becomes first state to cap out-of-pocket insulin costs
The Hill
Thu, 05/23/19 - 10:41 pm
Colorado
insulin
drug pricing
co-pays
diabetes
Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart
BioSpace
Thu, 05/23/19 - 12:28 pm
Eli Lilly
drug pricing
generics
insulin
diabetes
Lispro
KwikPens
Interchangeable Insulins: FDA Holds Public Meeting
RAPS.org
Mon, 05/13/19 - 08:13 pm
diabetes
insulin
biosimilars
FDA
biosimilar insulin
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »